{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:56:03Z","timestamp":1773939363060,"version":"3.50.1"},"reference-count":199,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and\/or enhance many products, including medicinal products. This technology has achieved considerable progress in the oncology field in recent years. Most chemotherapeutic agents are not specific to the cancer cells they are intended to treat, and they can harm healthy cells, leading to numerous adverse effects. Due to this non-specific targeting, it is not feasible to administer high doses that may harm healthy cells. Moreover, low doses can cause cancer cells to acquire resistance, thus making them hard to kill. A solution that could potentially enhance drug targeting and delivery lies in understanding the complexity of nanotechnology. Engineering pharmaceutical and natural products into nano-products can enhance the diagnosis and treatment of cancer. Novel nano-formulations such as liposomes, polymeric micelles, dendrimers, quantum dots, nano-suspensions, and gold nanoparticles have been shown to enhance the delivery of drugs. Improved delivery of chemotherapeutic agents targets cancer cells rather than healthy cells, thereby preventing undesirable side effects and decreasing chemotherapeutic drug resistance. Nanotechnology has also revolutionized cancer diagnosis by using nanotechnology-based imaging contrast agents that can specifically target and therefore enhance tumor detection. In addition to the delivery of drugs, nanotechnology can be used to deliver nutraceuticals like phytochemicals that have multiple properties, such as antioxidant activity, that protect cells from oxidative damage and reduce the risk of cancer. There have been multiple advancements and implications for the use of nanotechnology to enhance the delivery of both pharmaceutical and nutraceutical products in cancer prevention, diagnosis, and treatment.<\/jats:p>","DOI":"10.3390\/biomedicines8090347","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T21:11:32Z","timestamp":1600031492000},"page":"347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management"],"prefix":"10.3390","volume":"8","author":[{"given":"Lavinia","family":"Salama","sequence":"first","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Pastor","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Stone","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-015X","authenticated-orcid":false,"given":"Shaker","family":"Mousa","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0974-2077.63301","article-title":"Nanotechnology: The future medicine","volume":"3","author":"Saini","year":"2010","journal-title":"J. Cutan. Aesthet. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.20892\/j.issn.2095-3941.2017.0054","article-title":"Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer","volume":"14","author":"Zhang","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: Classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10717544.2014.882469","article-title":"A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery","volume":"22","author":"Paliwal","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajps.2013.07.009","article-title":"Application of cationic liposomes for delivery of nucleic acids","volume":"8","author":"Shim","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1211\/jpp.59.4.0001","article-title":"pH-sensitive liposomes-principle and application in cancer therapy","volume":"59","author":"Karanth","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11095-018-2490-6","article-title":"Cationic liposomes: A flexible vaccine delivery system for physicochemically diverse antigenic peptides","volume":"35","author":"Heuts","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.2174\/092986712803833362","article-title":"Immunoliposomes","volume":"19","author":"Paszko","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15171\/apb.2017.002","article-title":"Application of various types of liposomes in drug delivery systems","volume":"7","author":"Alavi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lungu, I.I., Grumezescu, A.M., Volceanov, A., and Andronescu, E. (2019). Nanobiomaterials used in cancer therapy: An up-to-date overview. Molecules, 24.","DOI":"10.3390\/molecules24193547"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N., and Khan, W. (2017). Liposomal formulations in clinical use: An updated review. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020012"},{"key":"ref_14","unstructured":"(2020, January 02). Doxil Package Insert. Available online: http:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/DOXIL-pi.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.colsurfb.2015.07.042","article-title":"Liposomes loaded with hydrophilic magnetite nanoparticles: Preparation and application as contrast agents for magnetic resonance imaging","volume":"135","author":"German","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1845637","DOI":"10.1155\/2019\/1845637","article-title":"Nanoparticle-based paramagnetic contrast agents for magnetic resonance imaging","volume":"2019","author":"Pellico","year":"2019","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2018.08.034","article-title":"Nanomedicines for the treatment of hematological malignancies","volume":"287","author":"Deshantri","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11705-016-1582-2","article-title":"Polymeric micelle nanocarriers in cancer research","volume":"10","author":"Shin","year":"2016","journal-title":"Front. Chem. Sci. Eng."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.2174\/138161206779026245","article-title":"Polymeric micelles for drug delivery","volume":"12","author":"Croy","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-014-0251-3","article-title":"Polymeric micelles for multi-drug delivery in cancer","volume":"16","author":"Cho","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/1385772X.2012.688328","article-title":"Polymeric micelles: Authoritative aspects for drug delivery","volume":"15","author":"Kulthe","year":"2012","journal-title":"Des. Monomers Polym."},{"key":"ref_22","first-page":"742","article-title":"Progress in nanomedicine: Approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"Pharm. Ther."},{"key":"ref_23","unstructured":"(2020, January 02). Taxol\u00ae (Paclitaxel) Injection Package Insert, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020262s049lbl.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1590\/0001-3765201820170387","article-title":"Perspectives of dendrimer-based nanoparticles in cancer therapy","volume":"90","author":"Castro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: Synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Palmerston Mendes, L., Pan, J., and Torchilin, V.P. (2017). Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules (Basel Switz.), 22.","DOI":"10.3390\/molecules22091401"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cncr.22035","article-title":"Emerging implications of nanotechnology on cancer diagnostics and therapeutics","volume":"107","author":"Cuenca","year":"2006","journal-title":"Cancer"},{"key":"ref_28","first-page":"151","article-title":"Quantum dots for cancer research: Current status, remaining issues, and future perspectives","volume":"9","author":"Fang","year":"2012","journal-title":"Cancer Biol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1039\/C4AN00294F","article-title":"Quantum dots in diagnostics and detection: Principles and paradigms","volume":"139","author":"Pisanic","year":"2014","journal-title":"Analyst"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.32607\/20758251-2011-3-1-29-47","article-title":"Quantum dots for molecular diagnostics of tumors","volume":"3","author":"Zdobnova","year":"2011","journal-title":"Acta Nat."},{"key":"ref_31","first-page":"1323","article-title":"Near-infrared quantum dots for HER2 localization and imaging of cancer cells","volume":"9","author":"Rizvi","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1109\/TNB.2005.850478","article-title":"Carbon nanotubes for biomedical applications","volume":"4","author":"Sinha","year":"2005","journal-title":"IEEE Trans. Nanobioscience"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2967\/jnumed.107.041723","article-title":"Carbon nanotubes: Potential benefits and risks of nanotechnology in nuclear medicine","volume":"48","author":"Reilly","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/ar700089b","article-title":"Functionalized carbon nanotubes in drug design and discovery","volume":"41","author":"Prato","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/acsomega.8b03212","article-title":"Sustained releasing of methotrexate from injectable and thermosensitive chitosan-carbon nanotube hybrid hydrogels effectively controls tumor cell growth","volume":"4","author":"Saeednia","year":"2019","journal-title":"ACS Omega"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/17435390.2019.1651920","article-title":"Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes","volume":"13","author":"Dong","year":"2019","journal-title":"Nanotoxicology"},{"key":"ref_37","first-page":"639","article-title":"Medicinal applications of fullerenes","volume":"2","author":"Bakry","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2298\/SARH1604222B","article-title":"Carbon nanomaterials: Biologically active fullerene derivatives","volume":"144","author":"Bogdanovic","year":"2016","journal-title":"Srp. Arh. Celok. Lek."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1038\/ncomms6988","article-title":"Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor","volume":"6","author":"Liu","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Singh, P., Pandit, S., Mokkapati, V.R.S.S., Garg, A., Ravikumar, V., and Mijakovic, I. (2018). Gold nanoparticles in diagnostics and therapeutics for human cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071979"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Surendran, S.P., Moon, M.J., Park, R., and Jeong, Y.Y. (2018). Bioactive nanoparticles for cancer immunotherapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123877"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105554","DOI":"10.1016\/j.biocel.2019.06.002","article-title":"Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study","volume":"114","author":"Khademi","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/imt-2018-0029","article-title":"Gold nanoparticles-mediated photothermal therapy and immunotherapy","volume":"10","author":"Liu","year":"2018","journal-title":"Immunotherapy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in cancer treatment","volume":"16","author":"Sztandera","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Huang, W., and Zhang, C. (2018). Tuning the size of poly(lactic-co-glycolic acid) (PLGA) nanoparticles fabricated by nanoprecipitation. Biotechnol. J., 13.","DOI":"10.1002\/biot.201700203"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kim, K.-T., Lee, J.-Y., Kim, D.-D., Yoon, I.-S., and Cho, H.-J. (2019). Recent progress in the development of poly(lactic-co-glycolic acid)-based nanostructures for cancer imaging and therapy. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11060280"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109257","DOI":"10.1016\/j.biopha.2019.109257","article-title":"Polymer-based nanoparticles for chemo\/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma","volume":"118","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IJN.S198353","article-title":"Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: State of the art, emerging technologies, and perspectives","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijpharm.2017.11.031","article-title":"Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation","volume":"535","author":"Widmer","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_50","first-page":"738","article-title":"Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment","volume":"7","author":"Wu","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1039\/C8BM01528G","article-title":"Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells","volume":"7","author":"Carvalho","year":"2019","journal-title":"Biomater. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJN.S187886","article-title":"Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models","volume":"14","author":"Lugert","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1700932","DOI":"10.1002\/adhm.201700932","article-title":"Iron oxide nanoparticles: Innovative tool in cancer diagnosis and therapy","volume":"7","author":"Martinkova","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"eAO4786","DOI":"10.31744\/einstein_journal\/2019AO4786","article-title":"Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model","volume":"17","author":"Rego","year":"2019","journal-title":"Einstein (Sao Paulo Braz.)"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17425247.2019.1554647","article-title":"Magnetic iron oxide nanoparticles for drug delivery: Applications and characteristics","volume":"16","author":"Vangijzegem","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/hv.22130","article-title":"How can nanotechnology help membrane vesicle-based cancer immunotherapy development?","volume":"9","author":"Tian","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Antimisiaris, S.G., Mourtas, S., and Marazioti, A. (2018). Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics, 10.","DOI":"10.20944\/preprints201810.0507.v1"},{"key":"ref_59","first-page":"1","article-title":"Engineering of exosomes to target cancer metastasis","volume":"13","author":"Zhang","year":"2019","journal-title":"Cell. Mol. Bioeng."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Parodi, A., Miao, J., Soond, S.M., Rudzi\u0144ska, M., and Zamyatnin, A.A. (2019). Albumin nanovectors in cancer therapy and imaging. Biomolecules, 9.","DOI":"10.3390\/biom9060218"},{"key":"ref_61","unstructured":"(2020, January 28). Abraxane Package Insert, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021660s037lbl.pdf."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11095-010-0241-4","article-title":"Nanoparticle delivery systems in cancer vaccines","volume":"28","author":"Krishnamachari","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-009-0666-9","article-title":"A virosomal formulated Her-2\/neu multi-peptide vaccine induces Her-2\/neu-specific immune responses in patients with metastatic breast cancer: A phase I study","volume":"119","author":"Wiedermann","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nam, L., Coll, C., Erthal, L.C.S., de la Torre, C., Serrano, D., Mart\u00ednez-M\u00e1\u00f1ez, R., Santos-Mart\u00ednez, M.J., and Ruiz-Hern\u00e1ndez, E. (2018). Drug delivery nanosystems for the localized treatment of glioblastoma multiforme. Materials, 11.","DOI":"10.3390\/ma11050779"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Vallet-Reg\u00ed, M., Colilla, M., Izquierdo-Barba, I., and Manzano, M. (2017). Mesoporous silica nanoparticles for drug delivery: Current insights. Molecules, 23.","DOI":"10.3390\/molecules23010047"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/elsc.201800038","article-title":"Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery","volume":"18","year":"2018","journal-title":"Eng. Life Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1049\/iet-nbt.2019.0239","article-title":"Preparation and characterisation of silica-based nanoparticles for cisplatin release on cancer brain cells","volume":"14","author":"Almaguer","year":"2020","journal-title":"IET Nanobiotechnol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rahmani, S., Budimir, J., Sejalon, M., Daurat, M., Aggad, D., Viv\u00e8s, E., Raehm, L., Garcia, M., Lichon, L., and Gary-Bobo, M. (2019). Large pore mesoporous silica and organosilica nanoparticles for pepstatin a delivery in breast cancer cells. Molecules, 24.","DOI":"10.3390\/molecules24020332"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.2147\/IJN.S214377","article-title":"Magnetic and pH dual-responsive nanoparticles for synergistic drug-resistant breast cancer chemo\/photodynamic therapy","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0958-1669(00)00082-3","article-title":"Applications of nanotechnology to biotechnology commentary","volume":"11","author":"West","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Kherlopian, A.R., Song, T., Duan, Q., Neimark, M.A., Po, M.J., Gohagan, J.K., and Laine, A.F. (2008). A review of imaging techniques for systems biology. BMC Syst. Biol., 2.","DOI":"10.1186\/1752-0509-2-74"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Riley, R.S., O\u2019Sullivan, R.K., Potocny, A.M., Rosenthal, J., and Day, E.S. (2018). Evaluating nanoshells and a potent biladiene photosensitizer for dual photothermal and photodynamic therapy of triple negative breast cancer cells. Nanomaterials, 8.","DOI":"10.3390\/nano8090658"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.rli.0000199292.88189.0f","article-title":"Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications","volume":"41","author":"Klibanov","year":"2006","journal-title":"Invest. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ultras.2007.11.002","article-title":"Drug-loaded nano\/microbubbles for combining ultrasonography and targeted chemotherapy","volume":"48","author":"Gao","year":"2008","journal-title":"Ultrasonics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2019.05.039","article-title":"Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer","volume":"566","author":"Akbaba","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","article-title":"Niosome: A future of targeted drug delivery systems","volume":"1","author":"Kazi","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7372306","DOI":"10.1155\/2016\/7372306","article-title":"Niosomes as nanoparticular drug carriers: Fundamentals and recent applications","volume":"2016","author":"Seleci","year":"2016","journal-title":"J. Nanomater."},{"key":"ref_78","first-page":"498","article-title":"Niosomes: A novel drug delivery system","volume":"1","author":"Madhav","year":"2011","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"ref_79","first-page":"21","article-title":"Nanosuspension: A novel approch to enhance solubility of poorly water soluble drugs\u2014A review","volume":"5","author":"Patel","year":"2016","journal-title":"Int. J. Adv. Pharm."},{"key":"ref_80","first-page":"2329","article-title":"In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer","volume":"11","author":"Yang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.2147\/IJN.S196453","article-title":"Sustained delivery of a camptothecin prodrug\u2014CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity","volume":"14","author":"Dong","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1038\/s41598-020-65773-9","article-title":"Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo","volume":"10","author":"Huang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/etc.3039","article-title":"Nanopharmaceuticals: Tiny challenges for the environmental risk assessment of pharmaceuticals","volume":"35","author":"Berkner","year":"2016","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: Recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1038\/s41598-019-44979-6","article-title":"Pharmacokinetics, biodistribution, and anti-angiogenesis efficacy of diamino propane tetraiodothyroacetic acid-conjugated biodegradable polymeric nanoparticle","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.7150\/thno.18879","article-title":"PSMA-targeted theranostic nanocarrier for prostate cancer","volume":"7","author":"Flores","year":"2017","journal-title":"Theranostics"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Darwish, N.H.E., Sudha, T., Godugu, K., Bharali, D.J., Elbaz, O., El-Ghaffar, H.A.A., Azmy, E., Anber, N., and Mousa, S.A. (2019). Novel targeted nano-parthenolide molecule against NF-kB in acute myeloid leukemia. Molecules, 24.","DOI":"10.3390\/molecules24112103"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nano.2016.08.017","article-title":"Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer","volume":"13","author":"Bharali","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/IJN.S123742","article-title":"Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac","volume":"12","author":"Sudha","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2217\/nnm-2016-0315","article-title":"Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac","volume":"12","author":"Sudha","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"ref_91","first-page":"2764","article-title":"Nano-targeted delivery of toremifene, an estrogen receptor-\u03b1 blocker in prostate cancer","volume":"32","author":"Hariri","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Jampilek, J., Kos, J., and Kralova, K. (2019). Potential of nanomaterial applications in dietary supplements and foods for special medical purposes. Nanomaterials, 9.","DOI":"10.3390\/nano9020296"},{"key":"ref_93","first-page":"218","article-title":"Delivery of nutraceuticals using nanotechnology","volume":"24","author":"Wiwanitkit","year":"2013","journal-title":"Agro Food Ind. Hi Tech."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W","article-title":"Phytochemicals: Nutraceuticals and human health","volume":"80","author":"Dillard","year":"2000","journal-title":"J. Sci. Food Agric."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2017.11.002","article-title":"Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment","volume":"413","author":"Chikara","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcancer.2016.09.001","article-title":"Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy","volume":"40\u201341","author":"Dandawate","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2174\/138945012804545551","article-title":"Indole compounds against breast cancer: Recent developments","volume":"13","author":"Biersack","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"ref_98","first-page":"837","article-title":"Anticancer properties of capsaicin against human cancer","volume":"36","author":"Clark","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_99","first-page":"56","article-title":"Nutraceuticals: Definition, applied nanoengineering in their production and applications","volume":"5","author":"Lidia","year":"2019","journal-title":"Int. J. Biosen. Bioelectron."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2009.07.007","article-title":"Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization","volume":"139","author":"Jeong","year":"2009","journal-title":"J. Control. Release"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2007.04.014","article-title":"Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells","volume":"122","author":"Blanco","year":"2007","journal-title":"J. Control. Release"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41598-017-02937-0","article-title":"\u0392-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/1061186X.2015.1073296","article-title":"Nanotechnology-enabled delivery of NQO1 bioactivatable drugs","volume":"23","author":"Ma","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","article-title":"Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration","volume":"416","author":"Tsai","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1002\/jcp.26538","article-title":"Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer","volume":"233","author":"Marjaneh","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10965-020-02092-7","article-title":"Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells","volume":"27","author":"Prabhuraj","year":"2020","journal-title":"J. Polymer Res."},{"key":"ref_107","first-page":"3867","article-title":"Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy","volume":"29","author":"Mukerjee","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/aps.2012.34","article-title":"Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-p-glycoprotein in drug resistance cancer cells","volume":"33","author":"Punfa","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nano.2009.05.009","article-title":"Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells","volume":"6","author":"Das","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1021\/bm800683f","article-title":"Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells","volume":"9","author":"Sahu","year":"2008","journal-title":"Biomacromolecules"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-5-3","article-title":"Polymeric nanoparticle-encapsulated curcumin (\u201cnanocurcumin\u201d): A novel strategy for human cancer therapy","volume":"5","author":"Bisht","year":"2007","journal-title":"J. Nanobiotechnology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.07.021","article-title":"Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis","volume":"398","author":"Mulik","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"He, Y., Liu, H., Bian, W., Liu, Y., Liu, X., Ma, S., Zheng, X., Du, Z., Zhang, K., and Ouyang, D. (2019). Molecular interactions for the curcumin-polymer complex with enhanced anti-inflammatory effects. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090442"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"18187","DOI":"10.1038\/s41598-019-54752-4","article-title":"Curcumin to promote the synthesis of silver nps and their self-assembly with a thermoresponsive polymer in core-shell nanohybrids","volume":"9","author":"Guarrotxena","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1016\/j.biomaterials.2008.07.008","article-title":"The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases","volume":"29","author":"Gao","year":"2008","journal-title":"Biomaterials"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/annonc\/mdp499","article-title":"Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway","volume":"21","author":"Jin","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/nn901385y","article-title":"Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in HeLa cells","volume":"4","author":"Contreras","year":"2010","journal-title":"ACS Nano"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.21873\/anticanres.11193","article-title":"Dibenzoyl-methane derivatives as a potential and exciting new therapy for the treatment of childhood bone cancer","volume":"36","author":"Almelah","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1158\/0008-5472.CAN-09-0597","article-title":"Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model","volume":"69","author":"Khor","year":"2009","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fphar.2020.00226","article-title":"Dihydroartemisinin-loaded magnetic nanoparticles for enhanced chemodynamic therapy","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1038\/celldisc.2017.42","article-title":"Dihydroartemisinin selectively inhibits PDGFR\u03b1-positive ovarian cancer growth and metastasis through inducing degradation of PDGFR\u03b1 protein","volume":"3","author":"Li","year":"2017","journal-title":"Cell Discov."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"8759745","DOI":"10.1155\/2018\/8759745","article-title":"Anticancer effects of dihydroartemisinin on human esophageal cancer cells in vivo","volume":"2018","author":"Jiang","year":"2018","journal-title":"Anal. Cell. Pathol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"110824","DOI":"10.1016\/j.colsurfb.2020.110824","article-title":"Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed\/ellagic acid synergistic breast cancer therapy","volume":"188","author":"Ali","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Ceci, C., Lacal, P.M., Tentori, L., De Martino, M.G., Miano, R., and Graziani, G. (2018). Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients, 10.","DOI":"10.3390\/nu10111756"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Neamatallah, T., El-Shitany, N., Abbas, A., Eid, B.G., Harakeh, S., Ali, S., and Mousa, S. (2020). Nano ellagic acid counteracts cisplatin-induced upregulation in OAT1 and OAT3: A possible nephroprotection mechanism. Molecules, 25.","DOI":"10.3390\/molecules25133031"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/carcin\/bgt321","article-title":"Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model","volume":"35","author":"Khan","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"45521","DOI":"10.1038\/srep45521","article-title":"Preparation and characterization of (\u2212)-epigallocatechin-3-gallate (EGCG)-loaded nanoparticles and their inhibitory effects on human breast cancer MCF-7 cells","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5813793","DOI":"10.1155\/2017\/5813793","article-title":"Therapeutic potential of epigallocatechin gallate nanodelivery systems","volume":"2017","author":"Granja","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.7314\/APJCP.2014.15.21.9159","article-title":"Apoptotic effects of eugenol-loaded nanoemulsions in human colon and liver cancer cell lines","volume":"15","author":"Majeed","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12906-018-2392-5","article-title":"Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells","volume":"18","author":"Abdullah","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jddst.2018.11.001","article-title":"Cytotoxicity and antibacterial activities of new chemically synthesized magnetic nanoparticles containing eugenol","volume":"49","author":"Shahabadi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1808646","DOI":"10.1002\/adfm.201808646","article-title":"Poly(ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced colon cancer therapy","volume":"29","author":"Zheng","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13578-015-0041-y","article-title":"Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles","volume":"5","author":"Thakkar","year":"2015","journal-title":"Cell Biosci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jat.3018","article-title":"Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells","volume":"34","author":"Saeed","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"110842","DOI":"10.1016\/j.colsurfb.2020.110842","article-title":"Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy","volume":"189","author":"Wang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_136","first-page":"2306","article-title":"Development of genistein-pegylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells","volume":"10","author":"Pool","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_137","first-page":"2461","article-title":"Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells","volume":"10","author":"Zhang","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijpharm.2018.04.060","article-title":"Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer","volume":"545","author":"Tang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2217\/nnm-2018-0196","article-title":"Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined cox-2 inhibitor\/herbal therapy of breast cancer","volume":"13","author":"AbdElhamid","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1535-7163.MCT-11-0999","article-title":"Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells","volume":"11","author":"Ponnurangam","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_141","first-page":"673","article-title":"Anticancer activity of honokiol against lymphoid malignant cells via activation of ROS-jnk and attenuation of Nrf2 and NF-kappaB","volume":"21","author":"Gao","year":"2016","journal-title":"J. BUON"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.amjsurg.2014.09.014","article-title":"Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway","volume":"208","author":"Kaushik","year":"2014","journal-title":"Am. J. Surg."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.phrs.2016.11.038","article-title":"Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells","volume":"115","author":"Lu","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.taap.2016.05.018","article-title":"Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53\/PI3K\/Akt\/mTOR signaling pathway","volume":"304","author":"Lin","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Fuster, M.G., Carissimi, G., Montalb\u00e1n, M.G., and V\u00edllora, G. (2020). Improving anticancer therapy with naringenin-loaded silk fibroin nanoparticles. Nanomaterials, 10.","DOI":"10.3390\/nano10040718"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Morais, R.P., Novais, G.B., Sangenito, L.S., Santos, A.L.S., Priefer, R., Morsink, M., Mendon\u00e7a, M.C., Souto, E.B., Severino, P., and Cardoso, J.C. (2020). Naringenin-functionalized multi-walled carbon nanotubes: A potential approach for site-specific remote-controlled anticancer delivery for the treatment of lung cancer cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124557"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03639045.2020.1747485","article-title":"Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: Design, optimization, and in vitro studies","volume":"46","author":"Akhter","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Goh, J.X.H., Tan, L.T.-H., Goh, J.K., Chan, K.G., Pusparajah, P., Lee, L.-H., and Goh, B.-H. (2019). Nobiletin and derivatives: Functional compounds from citrus fruit peel for colon cancer chemoprevention. Cancers, 11.","DOI":"10.3390\/cancers11060867"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh, M., Zarrabi, A., Saberifar, S., Hashemi, F., Hushmandi, K., Hashemi, F., Moghadam, E.R., Mohammadinejad, R., Najafi, M., and Garg, M. (2020). Nobiletin in cancer therapy: How this plant derived-natural compound targets various oncogene and onco-suppressor pathways. Biomedicines, 8.","DOI":"10.3390\/biomedicines8050110"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acs.jafc.7b03953","article-title":"Enhancement of anti-inflammatory properties of nobiletin in macrophages by a nano-emulsion preparation","volume":"66","author":"Liao","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Niazvand, F., Orazizadeh, M., Khorsandi, L., Abbaspour, M., Mansouri, E., and Khodadadi, A. (2019). Effects of quercetin-loaded nanoparticles on MCF-7 human breast cancer cells. Medicina, 55.","DOI":"10.3390\/medicina55040114"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13578-020-00397-0","article-title":"Quercetin and cancer: New insights into its therapeutic effects on ovarian cancer cells","volume":"10","author":"Vafadar","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.colsurfb.2019.03.037","article-title":"Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells","volume":"178","author":"Tiwari","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3892\/ijo.2017.3886","article-title":"Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells","volume":"50","author":"Ren","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","article-title":"Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles","volume":"133","author":"Li","year":"2009","journal-title":"J. Control. Release"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.2147\/IJN.S204443","article-title":"Development of resveratrol-conjugated gold nanoparticles: Interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers","volume":"14","author":"Thipe","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2009.10.011","article-title":"The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol","volume":"390","author":"Teskac","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.2147\/IJN.S206899","article-title":"Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release","volume":"14","author":"Shahein","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0974-8490.199774","article-title":"The influence of pluronic F68 and F127 nanocarrier on physicochemical properties, in vitro release, and antiproliferative activity of thymoquinone drug","volume":"9","author":"Shaarani","year":"2017","journal-title":"Pharmacogn. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.2147\/IJN.S35329","article-title":"Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: A pharmacoscintigraphic study","volume":"7","author":"Alam","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"118721","DOI":"10.1016\/j.ijpharm.2019.118721","article-title":"Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity","volume":"572","author":"Zheng","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1038\/s41598-018-29692-0","article-title":"Redox-responsive self-assembly PEG nanoparticle enhanced triptolide for efficient antitumor treatment","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.18632\/oncotarget.7073","article-title":"Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Razak, S., Afsar, T., Ullah, A., Almajwal, A., Alkholief, M., Alshamsan, A., and Jahan, S. (2018). Taxifolin, a natural flavonoid interacts with cell cycle regulators causes cell cycle arrest and causes tumor regression by activating Wnt\/\u03b2 -catenin signaling pathway. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4959-4"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10876-019-01642-4","article-title":"Meticulous taxifolin releasing performance by the zinc oxide nanoparticles: As a short road to drug delivery system for cancer therapeutics","volume":"31","author":"Sundraraman","year":"2020","journal-title":"J. Cluster Sci."},{"key":"ref_166","first-page":"6055","article-title":"Natural product-based nanomedicine: Recent advances and issues","volume":"10","author":"Watkins","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3892\/ijo.2017.3890","article-title":"Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction","volume":"50","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3892\/etm.2017.4965","article-title":"Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K\/AKT and NF-\u03baB signaling pathways in vitro","volume":"14","author":"Luo","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejps.2016.10.019","article-title":"pH-sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer","volume":"96","author":"Li","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Shao, J., Fang, Y., Zhao, R., Chen, F., Yang, M., Jiang, J., Chen, Z., Yuan, X., and Jia, L. (2020). Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid. Asian J. Pharm. Sci.","DOI":"10.1016\/j.ajps.2020.03.001"},{"key":"ref_171","first-page":"467147","article-title":"Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid","volume":"2013","author":"Ferreira","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.msec.2015.04.022","article-title":"Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes","volume":"53","author":"Zhao","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1007\/s00253-016-7360-8","article-title":"Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor","volume":"100","author":"Jin","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Godugu, K., El-Far, A.H., Al Jaouni, S., and Mousa, S.A. (2020). Nanoformulated Ajwa (Phoenix Dactylifera) bioactive compounds improve the safety of doxorubicin without compromising its anticancer efficacy in breast cancer. Molecules, 25.","DOI":"10.3390\/molecules25112597"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2147\/IJN.S241702","article-title":"Antiviral activity of chitosan nanoparticles encapsulating curcumin against hepatitis c virus genotype 4a in human hepatoma cell lines","volume":"15","author":"Loutfy","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2217\/fon-2019-0635","article-title":"Functionalized nano-targeted moieties in management of prostate cancer","volume":"16","author":"Salaheldin","year":"2020","journal-title":"Future Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2147\/IJN.S238256","article-title":"Nanoformulated bioactive compounds derived from different natural products combat pancreatic cancer cell proliferation","volume":"15","author":"Mousa","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Sudha, T., El-Far, A.H., Mousa, D.S., and Mousa, S.A. (2020). Resveratrol and its nanoformulation attenuate growth and the angiogenesis of xenograft and orthotopic colon cancer models. Molecules, 25.","DOI":"10.3390\/molecules25061412"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nantod.2019.02.005","article-title":"Clinical cancer nanomedicine","volume":"25","author":"Wolfram","year":"2019","journal-title":"Nano Today"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13045-019-0833-3","article-title":"Nanotechnology in cancer diagnosis: Progress, challenges and opportunities","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_181","unstructured":"(2020, July 31). A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03465618."},{"key":"ref_182","unstructured":"(2020, July 31). Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer after Neoadjuvant Radiochemotherapy (CALOR-NAT), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03550001."},{"key":"ref_183","unstructured":"(2020, July 31). Ferumoxytol\u2014Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01895829."},{"key":"ref_184","unstructured":"(2020, July 31). Diagnosis of Gastric Lesions with Na-Nose. Available online: https:\/\/www.centerwatch.com\/clinical-trials\/listings\/162656\/stomach-diseases-diagnosis-gastric-lesions-na-nose\/."},{"key":"ref_185","unstructured":"(2020, July 31). Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants with Diffuse Large B-Cell Lymphoma, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03656835."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2217\/nnm-2019-0130","article-title":"Cost-effectiveness of nanomedicine: Estimating the real size of nano-costs","volume":"14","author":"Bosetti","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acsnano.9b04266","article-title":"Integrating nanotechnology into cancer care","volume":"13","author":"Grodzinski","year":"2019","journal-title":"ACS Nano"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40580-019-0193-2","article-title":"Current trends and challenges in cancer management and therapy using designer nanomaterials","volume":"6","author":"Navya","year":"2019","journal-title":"Nano Converg."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1039\/C0AN00652A","article-title":"Gold nanoparticle probes for the detection of mercury, lead and copper ions","volume":"136","author":"Lin","year":"2011","journal-title":"Analyst"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: A phase 2 clinical trial","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1001\/amajethics.2019.347","article-title":"Regulating nanomedicine at the Food and Drug Administration","volume":"21","author":"Paradise","year":"2019","journal-title":"AMA J. Ethics"},{"key":"ref_193","unstructured":"U.S. Food & Drug Administration (2020, July 31). FDA\u2019s approach to regulation of nanotechnology products, Available online: https:\/\/www.fda.gov\/science-research\/nanotechnology-programs-fda\/fdas-approach-regulation-nanotechnology-products."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2019.05.044","article-title":"The beginning of the end of the nanomedicine hype","volume":"305","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: A review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Trans. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","article-title":"Cancer nanomedicines: Oversold or underappreciated?","volume":"14","author":"Lammers","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: Myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: An update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/9\/347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:09:30Z","timestamp":1760177370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/9\/347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":199,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["biomedicines8090347"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8090347","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]}}}